Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.
Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.
复制标题
腺相关病毒 2 介导的人造血祖细胞中的转导和红系谱系特异性表达。
DOI:
10.1007/978-3-642-80207-2_7
复制
发表时间:
1996
影响因子:
--
通讯作者:
Yoder,MC
中科院分区:
文献类型:
--
作者:
Srivastava,A;Wang,XS;Ponnazhagan,S;Zhou,SZ;Yoder,MC
Parvoviruses are among the smallest of the DNA-containing viruses that infect a wide variety of vertebrates (Sieglet al. 1985). Two parvoviruses of human origin, the nonpathogenic adeno-associated virus 2 (AAV) and the parvovirus B19, a common human pathogen, have been studied extensively (BernsandBohenzky1987;Brownet al. 1994). AAV requires coinfection with a helper virus, such as adenovirus or herpesvirus, for its optimal replication (Berns1990), but in the absence of a helper virus, the AAV genome establishes a latent infection in a site-specific manner (KotinandBerns1989;Kotinet al. 1990, 1991, 1992;Samulskiet al. 1991). B19, by contrast, is an autonomously replicating virus with a remarkable tropism for human erythroid progenitor cells (Ozawaet al. 1986, 1987;Yaegashiet al. 1989;Srivastavaand Lu 1988;Takahashiet al. 1990). We have described the construction of a recombinant AAV-B19 hybrid genome, in which we combined the remarkable features of these two parvoviruses, and speculated that such a hybrid vector may prove useful for high efficiency transduction of primary human hematopoietic progenitor cells (Srivastavaet al. 1989). Indeed, it has become increasingly clear that the AAV-based vector system may prove to be a useful alternative to the more commonly used retroviral and adenoviral vectors for its potential use in human gene therapy (Muzyczka1992;Carter1993;Srivastava1994). Despite these advances, a number of fundamental questions related to AAV remain unanswered. For example, the molecular details of viral assembly and the mechanism of viral entry into the host cell have not been rigorously analyzed. Furthermore, the feasibility of obtaining tissue-specific expression of an AAV-transduced gene has not been adequately addressed. Here, we provide experimental evidence to suggest that the vector assembly requires a precise signaling mechanism and that AAV infection of human cells is receptor-mediated. We also document erythroid lineage restricted expression following AAV-B19 hybrid vector-mediated transduction of primary human hematopoietic progenitor cells. Elucidation of the molecular details of these aspects of AAV biology will have important implications in the potential use of AAV as a vector in human gene therapy.
登录
查看更多内容
DOI:
--
发表时间:
1981
期刊:
Seminars in hematology (Print)
影响因子:
--
作者:
Marcus Dm;Kundu Sk;A. Suzuki
通讯作者:
A. Suzuki
DOI:
10.1073/pnas.87.6.2211
发表时间:
1990-03-01
影响因子:
11.1
作者:
KOTIN, RM;SINISCALCO, M;BERNS, KI
通讯作者:
BERNS, KI
影响因子:
5.4
作者:
N. Yaegashi;H. Shiraishi;T. Takeshita;M. Nakamura;A. Yajima;K. Sugamura
通讯作者:
K. Sugamura
影响因子:
2.6
作者:
Zhou,SZ;Broxmeyer,HE;Cooper,S;Harrington,MA;Srivastava,A
通讯作者:
Srivastava,A
影响因子:
6.5
作者:
A. E. G. Kr. vondem Borne;M. J. Bos;N. Joustra;J. Tromp;R. van Wijngaarden;P. Tetteroo
通讯作者:
P. Tetteroo